Elon Musk's Neuralink now valued at $5 billion after secondary trades

Per Business Insider

While most people know Elon Musk for his work on Tesla, SpaceX, and Twitter, another one of his companies, Neuralink, is also starting to gain more attention as its valuation rose to around $5 billion. This came as secondary sales resulted in an over-double increase in the company's valuation.

Neuralink is another one of Musk's companies that focuses on brain chips. Despite already carrying out some tests, the company is still reportedly far away from commercial clearance.

It was also reported that the company had a $2 billion valuation two years ago. Now, secondary trades made by employees, investors, or other shareholders have pushed Neuralink's valuation to over double at $5 billion.

This comes as Neuralink was able to get its human trial FDA approval, which would take the research a step further and finally see how the brain chips perform on humans.

Elon Musk has previously shared the potential behind Neuralink on top of how it could restore bodily functions. These include the possibility of telepathy as well as browsing the web, all in the chip.

In May 25, Neuralink reportedly received FDA approval, which could have sparked the private trades.

In December, it was noted that US law enforcement was investigating Neuralink over potential animal-welfare violations amid internal staff complaints regarding how the animal testing could be rushed, which would cause needless suffering and death.

This came as Neuralink is trying to develop a brain implant that could help paralyzed people walk again and cure other neurological ailments.

In November, it was reported that Elon Musk bought one Neuralink employee, 2 Boring company workers and 50 Tesla staff to Twitter. The person that the billionaire brought to Twitter was Andrew Musk, the son of Elon Musk's uncle.

This came as Elon Musk made major changes to Twitter and brought help from his other companies.

See flow at unusualwhales.com/flow.

Other News:

Resources:

Business Insider

Unusual Whales does not confirm the information's truthfulness or accuracy of the associated references, data, and cannot verify any of the information. Any content on this site or related pages are not intended to provide legal, tax, investment or insurance advice. Unusual Whales Inc. is not registered as a securities broker-dealer or an investment adviser with the U.S. Securities and Exchange Commission, the Financial Industry Regulatory Authority (“FINRA”) or any state securities regulatory authority. Nothing on Unusual Whales should be construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security by Unusual Whales or any third party. Options, investing, trading is risky, and losses are more expected than profits. Please do own research before investing. Please only subscribe after reading our full terms and understanding options and the market, and the inherent risks of trading. It is highly recommended not to trade on this, or any, information from Unusual Whales. Markets are risky, and you will likely lose some or all of your capital. Please check our terms for full details.
Any content on this site or related pages are not intended to provide legal, tax, investment or insurance advice. Unusual Whales Inc. is not registered as a securities broker-dealer or an investment adviser with the U.S. Securities and Exchange Commission, the Financial Industry Regulatory Authority (“FINRA”) or any state securities regulatory authority. Nothing on Unusual Whales should be construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security by Unusual Whales or any third party. Certain investment planning tools available on Unusual Whales may provide general investment education based on your input. You are solely responsible for determining whether any investment, investment strategy, security or related transaction is appropriate for you based on your personal investment objectives, financial circumstances and risk tolerance. You should consult your legal or tax professional regarding your specific situation. See terms for more information.